MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.
Key Details
- 1Path-IO uses routine pathological slides to identify features predicting immunotherapy response in NSCLC patients.
- 2In validation on over 1,000 patients across multiple institutions and countries, Path-IO significantly outperformed PD-L1 testing, the current standard biomarker.
- 3The AI model stratified patients into high- and low-risk groups, with high-risk patients experiencing double the probability of death or progression.
- 4Unlike 'black box' models, Path-IO leverages established tissue features for explainable, clinically translatable decision-making.
- 5Researchers are integrating radiomics and clinical data to further improve Path-IO's prediction accuracy and plan to include CT, genomics, and other multimodal data in the future.
- 6Prospective clinical validation is the next planned step, and the model may evolve into a digital twin framework for comprehensive clinical decision support.
Why It Matters
Path-IO's superior accuracy and explainability provide a pathway for more personalized and effective treatment decisions in oncology. The integration with radiomics and clinical imaging data signals a promising future for multimodal AI in precision medicine, especially for radiology and pathology collaborations.
Source
EurekAlert
Related News
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.
•EurekAlert
New AI Method Removes Artifacts in Super-Resolution Fluorescence Microscopy
Researchers unveil Adaptive-SN2N, a self-supervised deep learning framework that suppresses background artifacts in super-resolution fluorescence microscopy images.
•EurekAlert
Micro-CT and AI Reveal Hidden Damage in Coral Skeletons
Researchers combined micro-CT imaging and deep learning to detect subtle disease-induced changes in coral skeletons with high accuracy.